Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,334 | -2,562 | -7,381 | -3,342 | -1,920 |
| Depreciation Amortization | 606 | 606 | 188 | 67 | 49 |
| Other Working Capital | -1,968 | -328 | 2,051 | 1,507 | 778 |
| Other Operating Activity | 752 | 293 | 4,161 | 1,144 | 726 |
| Operating Cash Flow | $-4,944 | $-1,992 | $-981 | $-624 | $-367 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,587 | -215 | 767 | 592 | 394 |
| Debt Repayment | -215 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 5,972 | 5,972 | 255 | N/A | N/A |
| Common Stock Repurchased | -92 | -92 | N/A | N/A | N/A |
| Financing Cash Flow | $7,253 | $5,666 | $1,022 | $592 | $394 |
| Beginning Cash Position | 96 | 96 | 55 | 55 | 55 |
| End Cash Position | 2,405 | 3,770 | 96 | 23 | 82 |
| Net Cash Flow | $2,309 | $3,674 | $41 | $-32 | $27 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,944 | -1,992 | -981 | -624 | -367 |
| Free Cash Flow | -4,944 | -1,992 | -981 | -624 | -367 |